Bioxytran, Inc. Joins The Stock Day Podcast to Discuss The Commercialization of Their Stroke Treatment

Dec 03, 2019, 02:15 PM
The Stock Day Podcast welcomed
Bioxytran, Inc. (BIXT)(“the Company”), a developmental stage biotechnology company. CEO of the Company, Dr. David Platt, joined Stock Day host Everett Jolly.